Is insulin lispro safe in pregnant women: Does it cause any adverse outcomes on infants or mothers?

Diabetes Research and Clinical Practice

Volumn 80, Issue 3, 2008, Pages 444-448

  Aydin, Yusuf ^a   Berker, Dilek ^a   Direktör, Nafiye ^a   Ustün, Ihsan ^a   Tütüncü, Yasemin Ateş ^a   Işik, Serhat ^a   Delibaşi, Tuncay ^a   Guler, Serdar ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Diabetes mellitus; Insulin lispro; Pregnancy

Indexed keywords

HEMOGLOBIN A1C; INSULIN LISPRO; RECOMBINANT HUMAN INSULIN;

ADULT; AORTA DISEASE; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CONGENITAL MALFORMATION; CONTROLLED STUDY; DISEASE DURATION; DOWN SYNDROME; DRUG SAFETY; EXITUS; FALLOT TETRALOGY; FEMALE; GESTATIONAL AGE; HEART VENTRICLE SEPTUM DEFECT; HEMANGIOMA; HUMAN; KIDNEY CYST; LIVE BIRTH; MACROSOMIA; MAJOR CLINICAL STUDY; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; SPINA BIFIDA; SPONTANEOUS ABORTION; STILLBIRTH; TREATMENT OUTCOME; VAGINAL DELIVERY;

ABORTION, SPONTANEOUS; ADULT; BLOOD GLUCOSE; CESAREAN SECTION; CONGENITAL ABNORMALITIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; PREGNANCY; PREGNANCY IN DIABETICS; RETROSPECTIVE STUDIES; SAFETY;

EID: 43049165806     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.02.004     Document Type: Article

References (30)

1. Jovonic L., and Petit D.J. Treatment with insulin and its analogues in pregnancies complicated by diabetes. Diabetes Care 30 (2007) S220-S224
2. Carr K.J.E., Lindow S.W., and Mason E.A. The potential for the use of insulin lispro in pregnancy complicated by diabetes. J. Matern. Fetal Neonatal Med. 19 6 (2006) 323-329
3. Casson I.F., Clarke C.A., Howard C.V., McKendrick O., Pennycook S., Pharoah P.O., et al. Outcome of pregnancy in insulin-dependent diabetic women: results of a five-year population cohort study. BMJ 315 (1997) 275-278
4. Buchanan T. Pregnancy in preexisting diabetes. In: Harris M.I., Cowie C.C., Stern M.P., Boyko E.J., Reiber G.E., and Bennet P.H. (Eds). Diabetes in America. 2nd ed. (1995), NIH Publication Bethesda, MD; National İnstitutes of Health, National Institute of Diabetes and Digestive and Kidney Disease 719-734
5. Kitzmiller H., Buchanan T.A., Kjos S., Combs C.A., and Rarner R.E. Preconception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 19 (1996) 514-541
6. Cypryk K., Sobczak M., Pertynska-Marczewska M., Zawodniak-Szalapska M., Szymczak W., Wilczynski J., et al. Pregnancy complications and perinatal outcome in diabetic women treated with Humolog (insulin lispro) or regular human insulin during pregnancy. Med. Sci. Monit. 10 2 (2004) 129-132
7. Mecacci F., Cariqnani L., Cioni R., Bartoli E., Parretti E., La Torre P., et al. Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non-diabetic pregnant women. Eur. J. Obstet. Gynecol. Reprod. Biol. 111 1 (2003) 19-24
8. Buchbinder A., Miodovnik M., Khoury J., and Sibai B.M. Is the use of insulin lispro safe in pregnancy?. J. Matern. Fetal Neonatal Med. 11 4 (2002) 232-237
9. Calle-Pascual A.L., Bagazgoitia J., Calle J.R., Charro A., and Marañes J.P. Use of insulin lispro in pregnancy. Diabetes Nutr. Metab. 13 (2000) 173-177
10. Evers I.M., de Valk H.W., and Visser G.H.A. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ 10 (2004) 1136
11. Diamond T.D., and Kormas N. Possible fetal effect of insulin lispro. N. Engl. J. Med. 337 (1997) 1009-1010
12. Tamborlane W.V., Champion M.C., Rizza R.A., Service F.J., Bergenstal R.M., and KROC Collaborative Study Group. Observations on control of glycemia with conventional insulin therapy or continuous subcutaneous insulin infusion. Diabetes 34 Suppl. 3 (1985) 22-26
13. Reece E.A., and Homko C. Why do diabetic women deliver malformed infants?. Clin. Obstet. Gynecol. 43 (2000) 32-45
14. Langer O. Management of gestational diabetes. Clin. Obstet. Gynecol. 43 (2000) 106-115
15. Mello G., Parretti E., Mecacci F., Carbone C., Lucchetti R., Lagazio C., et al. Antropometric characteristics of full-term infants: effects of varying degrees of normal glucose metabolism. J. Perinat. Med. 25 (1997) 197-204
16. Garner P. Type 1 diabetes mellitus and pregnancy. Lancet 346 (1995) 157-161
17. Pedersen J. Weight and length at birth of infants of diabetic mothers. Acta Endocrinol. 16 (1954) 330-342
18. Temple R., Aldridge V., Greenwood R., Heyburn P., Sampson M., and Stanley K. Association between outcome of pregnancy and glycemic control in early pregnancy in type 1 diabetes: a population-based study. BMJ 325 (2002) 1275-1276
19. Simmons D. The utility and efficacy of the new insulins in the management of diabetes and pregnancy. Curr. Diab. Rep. 2 4 (2002) 331-336
20. Lapolla A., Dalfra M.G., and Fedele D. Insulin therapy in pregnancy complicated by diabetes: are insulin analogs a new tool?. Diabetes Metab. Res. Rev. 21 3 (2005) 241-252
21. Owens D., and Vora J. Insulin aspart. A review. Expert Opin. Drug Metab. Toxicol. 2 5 (2006) 783-804
22. Cypryk K., Sobczak M., Pertyńska-Marczewska M., Zawodniak-Szałapska M., Szymczak W., Wilczyński J., et al. Pregnancy complications and perinatal outcome in diabetic women treated with Humolog (insulin lispro) or regular human insulin during pregnancy. Med. Sci. Monit. 10 (2004) 129-132
23. Bhattacharyya A., Brown S., Hughes S., and Vice P.A. Insulin lispro and regular insulin in pregnancy. Q.J. Med. 94 (2001) 255-260
24. Evers I.M., de Valk H.W., Mol B.W., ter Braak E.W., and Visser G.H. Macrosomia despite good glycaemic control in type 1 diabetic pregnancy: results of a nationwide study in the Netherlands. Diabetologia 45 (2002) 1484-1489
25. Petitt D.J., Ospina P., Kolaczynski J.W., and Jovanovic L. Comparison of an insulin analog, insulin aspart, and regular human insulin with no insulin in gestational diabetes mellitus. Diabetes Care 26 (2006) 183-186
26. Garg S.K., Frias J.P., Anil S., Gottlieb P.A., MacKenzie T., and Jackson W.E. Insulin lispro therapy in pregnancies complicated by type 1 diabetes: glycemic control and maternal and fetal outcomes. Endocr. Pract. 9 3 (2003) 187-193
27. Scherbaum W.A., Lankish M.R., Pawlowski B., and Somville T. Insulin lispro in pregnancy-retrospective analysis of 33 cases and matched controls. Exp. Clin. Endocrinol. Diabetes 110 1 (2002) 6-9
28. Diabetes Control and Complications Trial Research Group. Pregnancy outcomes in the diabetes control and complications trial. Am. J. Obstet. Gynecol. 174 (1996) 1343-1353
29. Mills J.L., Simpson J.L., Driscoll S.G., Jovanovic-Peterson L., Van Allen M., Aarons J.H., et al. Incidence of spontaneous abortion among normal women and insulin dependent diabetic women whose pregnancies were identified within 21 days of conception. N. Engl. J. Med. 319 (1988) 1617-1623
30. Holleman F., and Hoekstra J.B. İnsulin lispro. N. Engl. J. Med. 337 (1997) 176-183